Omicron: Merck says its Covid-19 anti-viral pill will have similar efficacy against Omicron


content provided with permission by FXStreet

US pharmaceutical giant Merck said on Tuesday that it expected its antiviral pill to show similar activity against any new Covid-19 variant, including Omicron, according to Reuters. The company’s remarks come after the Regeneron CEO said live on CNBC earlier in the session that he thought Merck’s pill would no longer work.